Billingham girl and Heaton man receive one-of-a-kind cancer treatment
A North East man and teenage girl have received pioneering cancer treatment thanks to the support of a foundation founded by England legend Sir…
Stay updated with breaking news from Ruth Plummer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A North East man and teenage girl have received pioneering cancer treatment thanks to the support of a foundation founded by England legend Sir…
In a clinical trial, 22% of the patients treated with the AKT inhibitor drug ipatasertib had their tumors shrink.
In a trial 22% of cancer patients treated with AKT inhibitor ipatasertib had their tumors shrink.
In a trial matching new treatments to cancer patients based on the genetic make-up of their tumors, 22% of the patients treated with the AKT inhibitor drug ipatasertib had their tumors shrink.
A liquid biopsy test used for molecular profiling in patients with solid tumors also identified patients who were at risk for clonal hematopoiesis, which may develop into myeloid blood cancer.